[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Axitinib Market Research Report Forecast 2017 to 2022

November 2017 | 132 pages | ID: EA3884840B4EN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Delivery of the Report will take 2-3 working days once order is placed.

The Europe Axitinib Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Axitinib industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Axitinib market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs

Europe Axitinib Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals

Europe Axitinib Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Axitinib Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
1 AXITINIB MARKET OVERVIEW

1.1 Product Overview and Scope of Axitinib
1.2 Classification of Axitinib
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Axitinib
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Axitinib Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Axitinib (2012-2022)
  1.5.1 Europe Axitinib Sales and Growth Rate (2012-2022)
  1.5.2 Europe Axitinib Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON AXITINIB INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 AXITINIB MANUFACTURING COST ANALYSIS

3.1 Axitinib Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Axitinib

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Axitinib Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Axitinib Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE AXITINIB MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Axitinib Market Competition by Manufacturers
  5.1.1 Europe Axitinib Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Axitinib Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Axitinib (Volume and Value) by Type
  5.2.1 Europe Axitinib Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Axitinib Revenue and Market Share by Type (2012-2017)
5.3 Europe Axitinib (Volume and Value) by Countries
  5.3.1 Europe Axitinib Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Axitinib Revenue and Market Share by Countries (2012-2017)
5.4 Europe Axitinib (Volume) by Application

6 GERMANY AXITINIB (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Axitinib Sales and Value (2012-2017)
  6.1.1 Germany Axitinib Sales and Growth Rate (2012-2017)
  6.1.2 Germany Axitinib Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Axitinib Sales Price Trend (2012-2017)
6.2 Germany Axitinib Sales and Market Share by Manufacturers
6.3 Germany Axitinib Sales and Market Share by Type
6.4 Germany Axitinib Sales and Market Share by Application

7 FRANCE AXITINIB (VOLUME, VALUE AND SALES PRICE)

7.1 France Axitinib Sales and Value (2012-2017)
  7.1.1 France Axitinib Sales and Growth Rate (2012-2017)
  7.1.2 France Axitinib Revenue and Growth Rate (2012-2017)
  7.1.3 France Axitinib Sales Price Trend (2012-2017)
7.2 France Axitinib Sales and Market Share by Manufacturers
7.3 France Axitinib Sales and Market Share by Type
7.4 France Axitinib Sales and Market Share by Application

8 UK AXITINIB (VOLUME, VALUE AND SALES PRICE)

8.1 UK Axitinib Sales and Value (2012-2017)
  8.1.1 UK Axitinib Sales and Growth Rate (2012-2017)
  8.1.2 UK Axitinib Revenue and Growth Rate (2012-2017)
  8.1.3 UK Axitinib Sales Price Trend (2012-2017)
8.2 UK Axitinib Sales and Market Share by Manufacturers
8.3 UK Axitinib Sales and Market Share by Type
8.4 UK Axitinib Sales and Market Share by Application

9 RUSSIA AXITINIB (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Axitinib Sales and Value (2012-2017)
  9.1.1 Russia Axitinib Sales and Growth Rate (2012-2017)
  9.1.2 Russia Axitinib Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Axitinib Sales Price Trend (2012-2017)
9.2 Russia Axitinib Sales and Market Share by Manufacturers
9.3 Russia Axitinib Sales and Market Share by Type
9.4 Russia Axitinib Sales and Market Share by Application

10 ITALY AXITINIB (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Axitinib Sales and Value (2012-2017)
  10.1.1 Italy Axitinib Sales and Growth Rate (2012-2017)
  10.1.2 Italy Axitinib Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Axitinib Sales Price Trend (2012-2017)
10.2 Italy Axitinib Sales and Market Share by Manufacturers
10.3 Italy Axitinib Sales and Market Share by Type
10.4 Italy Axitinib Sales and Market Share by Application

11 SPAIN AXITINIB (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Axitinib Sales and Value (2012-2017)
  11.1.1 Spain Axitinib Sales and Growth Rate (2012-2017)
  11.1.2 Spain Axitinib Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Axitinib Sales Price Trend (2012-2017)
11.2 Spain Axitinib Sales and Market Share by Manufacturers
11.3 Spain Axitinib Sales and Market Share by Type
11.4 Spain Axitinib Sales and Market Share by Application

12 BENELUX AXITINIB (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Axitinib Sales and Value (2012-2017)
  12.1.1 Benelux Axitinib Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Axitinib Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Axitinib Sales Price Trend (2012-2017)
12.2 Benelux Axitinib Sales and Market Share by Manufacturers
12.3 Benelux Axitinib Sales and Market Share by Type
12.4 Benelux Axitinib Sales and Market Share by Application

13 EUROPE AXITINIB MANUFACTURERS ANALYSIS

13.1 Pfizer
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Allergan
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Alnylam Pharmaceuticals
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Amgen
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Angstrom Pharmaceuticals
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Acceleron Pharma
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Biocon
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Bionomics
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 CASI Pharmaceuticals
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE AXITINIB MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Axitinib Market Forecast by Type (2017-2022)
15.9 Europe Axitinib Market Forecast by Application (2017-2022)

16 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Axitinib
Table Classification of Axitinib
Figure Europe Sales Market Share of Axitinib by Type in 2016
Table Application of Axitinib
Figure Europe Sales Market Share of Axitinib by Application in 2016
Figure Germany Axitinib Revenue and Growth Rate (2012-2022)
Figure France Axitinib Revenue and Growth Rate (2012-2022)
Figure UK Axitinib Revenue and Growth Rate (2012-2022)
Figure Russia Axitinib Revenue and Growth Rate (2012-2022)
Figure Italy Axitinib Revenue and Growth Rate (2012-2022)
Figure Spain Axitinib Revenue and Growth Rate (2012-2022)
Figure Benelux Axitinib Revenue and Growth Rate (2012-2022)
Figure Europe Axitinib Sales and Growth Rate (2012-2022)
Figure Europe Axitinib Revenue and Growth Rate (2012-2022)
Table Europe Axitinib Sales of Key Manufacturers (2015 and 2016)
Table Europe Axitinib Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Axitinib Sales Share by Manufacturers
Figure 2016 Axitinib Sales Share by Manufacturers
Table Europe Axitinib Revenue by Manufacturers (2015 and 2016)
Table Europe Axitinib Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Axitinib Revenue Share by Manufacturers
Table 2016 Europe Axitinib Revenue Share by Manufacturers
Table Europe Axitinib Sales and Market Share by Type (2012-2017)
Table Europe Axitinib Sales Share by Type (2012-2017)
Figure Sales Market Share of Axitinib by Type (2012-2017)
Figure Europe Axitinib Sales Growth Rate by Type (2012-2017)
Table Europe Axitinib Revenue and Market Share by Type (2012-2017)
Table Europe Axitinib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Axitinib by Type (2012-2017)
Figure Europe Axitinib Revenue Growth Rate by Type (2012-2017)
Table Europe Axitinib Sales and Market Share by Countries (2012-2017)
Table Europe Axitinib Sales Share by Countries (2012-2017)
Figure Sales Market Share of Axitinib by Countries (2012-2017)
Table Europe Axitinib Revenue and Market Share by Countries (2012-2017)
Table Europe Axitinib Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Axitinib by Countries (2012-2017)
Table Europe Axitinib Sales and Market Share by Application (2012-2017)
Table Europe Axitinib Sales Share by Application (2012-2017)
Figure Sales Market Share of Axitinib by Application (2012-2017)
Figure Germany Axitinib Sales and Growth Rate (2012-2017)
Figure Germany Axitinib Revenue and Growth Rate (2012-2017)
Figure Germany Axitinib Sales Price Trend (2012-2017)
Table Germany Axitinib Sales by Manufacturers (2015 and 2016)
Table Germany Axitinib Market Share by Manufacturers (2015 and 2016)
Table Germany Axitinib Sales by Type (2015 and 2016)
Table Germany Axitinib Market Share by Type (2015 and 2016)
Table Germany Axitinib Sales by Application (2015 and 2016)
Table Germany Axitinib Market Share by Application (2015 and 2016)
Figure France Axitinib Sales and Growth Rate (2012-2017)
Figure France Axitinib Revenue and Growth Rate (2012-2017)
Figure France Axitinib Sales Price Trend (2012-2017)
Table France Axitinib Sales by Manufacturers (2015 and 2016)
Table France Axitinib Market Share by Manufacturers (2015 and 2016)
Table France Axitinib Sales by Type (2015 and 2016)
Table France Axitinib Market Share by Type (2015 and 2016)
Table France Axitinib Sales by Application (2015 and 2016)
Table France Axitinib Market Share by Application (2015 and 2016)
Figure UK Axitinib Sales and Growth Rate (2012-2017)
Figure UK Axitinib Revenue and Growth Rate (2012-2017)
Figure UK Axitinib Sales Price Trend (2012-2017)
Table UK Axitinib Sales by Manufacturers (2015 and 2016)
Table UK Axitinib Market Share by Manufacturers (2015 and 2016)
Table UK Axitinib Sales by Type (2015 and 2016)
Table UK Axitinib Market Share by Type (2015 and 2016)
Table UK Axitinib Sales by Application (2015 and 2016)
Table UK Axitinib Market Share by Application (2015 and 2016)
Figure Russia Axitinib Sales and Growth Rate (2012-2017)
Figure Russia Axitinib Revenue and Growth Rate (2012-2017)
Figure Russia Axitinib Sales Price Trend (2012-2017)
Table Russia Axitinib Sales by Manufacturers (2015 and 2016)
Table Russia Axitinib Market Share by Manufacturers (2015 and 2016)
Table Russia Axitinib Sales by Type (2015 and 2016)
Table Russia Axitinib Market Share by Type (2015 and 2016)
Table Russia Axitinib Sales by Application (2015 and 2016)
Table Russia Axitinib Market Share by Application (2015 and 2016)
Figure Italy Axitinib Sales and Growth Rate (2012-2017)
Figure Italy Axitinib Revenue and Growth Rate (2012-2017)
Figure Italy Axitinib Sales Price Trend (2012-2017)
Table Italy Axitinib Sales by Manufacturers (2015 and 2016)
Table Italy Axitinib Market Share by Manufacturers (2015 and 2016)
Table Italy Axitinib Sales by Type (2015 and 2016)
Table Italy Axitinib Market Share by Type (2015 and 2016)
Table Italy Axitinib Sales by Application (2015 and 2016)
Table Italy Axitinib Market Share by Application (2015 and 2016)
Figure Spain Axitinib Sales and Growth Rate (2012-2017)
Figure Spain Axitinib Revenue and Growth Rate (2012-2017)
Figure Spain Axitinib Sales Price Trend (2012-2017)
Table Spain Axitinib Sales by Manufacturers (2015 and 2016)
Table Spain Axitinib Market Share by Manufacturers (2015 and 2016)
Table Spain Axitinib Sales by Type (2015 and 2016)
Table Spain Axitinib Market Share by Type (2015 and 2016)
Table Spain Axitinib Sales by Application (2015 and 2016)
Table Spain Axitinib Market Share by Application (2015 and 2016)
Figure Benelux Axitinib Sales and Growth Rate (2012-2017)
Figure Benelux Axitinib Revenue and Growth Rate (2012-2017)
Figure Benelux Axitinib Sales Price Trend (2012-2017)
Table Benelux Axitinib Sales by Manufacturers (2015 and 2016)
Table Benelux Axitinib Market Share by Manufacturers (2015 and 2016)
Table Benelux Axitinib Sales by Type (2015 and 2016)
Table Benelux Axitinib Market Share by Type (2015 and 2016)
Table Benelux Axitinib Sales by Application (2015 and 2016)
Table Benelux Axitinib Market Share by Application (2015 and 2016)
Table Pfizer Basic Information List
Table Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Axitinib Sales Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Axitinib Sales Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Axitinib Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Axitinib Sales Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Angstrom Pharmaceuticals Axitinib Sales Market Share (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Acceleron Pharma Axitinib Sales Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biocon Axitinib Sales Market Share (2012-2017)
Table Bionomics Basic Information List
Table Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bionomics Axitinib Sales Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CASI Pharmaceuticals Axitinib Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Axitinib
Figure Manufacturing Process Analysis of Axitinib
Figure Axitinib Industrial Chain Analysis
Table Raw Materials Sources of Axitinib Major Manufacturers in 2016
Table Major Buyers of Axitinib
Table Distributors/Traders List
Figure Germany Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure Germany Axitinib Revenue and Growth Rate Forecast (2017-2022)
Figure France Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure France Axitinib Revenue and Growth Rate Forecast (2017-2022)
Figure UK Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure UK Axitinib Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure Russia Axitinib Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure Italy Axitinib Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure Spain Axitinib Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Axitinib Revenue and Growth Rate Forecast (2017-2022)
Table Europe Axitinib Sales Forecast by Type (2017-2022)
Table Europe Axitinib Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech


More Publications